Clinical Trials for Endometrial Cancer

Find clinical trials for endometrial cancer. Discover research opportunities and treatment options in your area.

239 Active Trials Found

Showing 239 trials on this page

Page 1 of 12

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT ID: NCT06943521

This clinical trial is studying a new medication called MT-4561 to see how safe and effective it is for patients with various advanced solid tumors, such as head and neck cancer, lung cancer, breas...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Houston, Texas, United States +1 more

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT ID: NCT06132958

This clinical trial is studying a new treatment called MK-2870, also known as sacituzumab tirumotecan, for women with endometrial cancer who have already received certain types of treatments. These...

Recruiting

Phase: PHASE3 Type: interventional Locations: Columbus, Ohio, United States, Warszawa, Mazowieckie, Poland +303 more

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

NCT ID: NCT06952504

This clinical trial is studying a new treatment approach for women with advanced or recurrent endometrial cancer, specifically those whose cancer cells have normal proteins (called proficient misma...

Recruiting

Phase: PHASE3 Type: interventional Locations: Miami Beach, Florida, United States, Jerusalem, , Israel +18 more

Application of da Vinci SP for Endometrial Cancer Surgical Staging

NCT ID: NCT07027046

This clinical trial is studying a new way to perform surgery for women with endometrial cancer, which is cancer that starts in the lining of the uterus. The surgery uses a special robotic system ca...

Not yet recruiting

Type: observational Locations: Milano, , Italy, Roma, , Italy

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

NCT ID: NCT06989112

The DESTINY-Endometrial01 trial is a research study looking at new treatment options for women with a specific type of advanced or recurrent endometrial cancer, which is a cancer of the uterus. Thi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Rochester, Minnesota, United States, Charlottesville, Virginia, United States +214 more

A Study of XMT-1660 in Participants With Solid Tumors

NCT ID: NCT05377996

This clinical trial is studying a new treatment called XMT-1660 for patients with certain types of solid tumors, including different forms of breast cancer, ovarian cancer, and others. The main goa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Boston, Massachusetts, United States +21 more

Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

NCT ID: NCT03832361

This clinical trial is studying a new treatment called mirvetuximab soravtansine (IMGN853) for women with a specific type of endometrial cancer that has certain characteristics, particularly those ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

NCT ID: NCT04683653

This clinical trial is studying a new way to give radiation treatment for women with endometrial cancer, which is cancer that starts in the lining of the uterus. The researchers want to see if givi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Salt Lake City, Utah, United States +4 more

A Cohort Study of Uterine Malignancies

NCT ID: NCT05635123

This clinical trial is studying cervical and endometrial cancers to better understand how factors like age, lifestyle, pregnancy history, and overall health affect these diseases. The researchers w...

Recruiting

Type: observational Locations: Hangzhou, Zhejiang, China

A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

NCT ID: NCT06738966

This clinical trial is investigating a new drug called BL0175 for treating postmenopausal women with certain types of advanced cancer, specifically breast, ovarian, and endometrial cancers that are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Changchun, Jilin, China, Sydney, New South Wales, Australia +1 more

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +20 more

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

NCT ID: NCT05489211

The TROPION-PanTumor03 clinical trial is exploring a new treatment called Datopotamab Deruxtecan (Dato-DXd) for patients with advanced solid tumors, including types of cancer like endometrial, gast...

Recruiting

Phase: PHASE2 Type: interventional Locations: Barcelona, , Spain, Los Angeles, California, United States +97 more

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

NCT ID: NCT06925724

This clinical trial is investigating a new treatment called ivonescimab for women with endometrial cancer or cervical cancer that has come back or spread after previous treatments. The goal is to s...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Harrison, New York, United States +5 more

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT ID: NCT06257264

This clinical trial is studying a new treatment called BG-68501 for patients with advanced-stage tumors, including certain types of breast cancer, lung cancer, ovarian cancer, and others. The main ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Brisbane, Queensland, Australia +44 more

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT ID: NCT05527184

This clinical trial, called IMGN151-1001, is testing a new treatment called IMGN151 for women with certain types of recurrent cancers, specifically endometrial cancer and high-grade ovarian, perito...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +37 more

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT ID: NCT06533059

This clinical trial is investigating a new medicine called ALTA2618 for adults with specific types of cancer that have a genetic mutation known as AKT1 E17K. The main goal of the study is to see ho...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Houston, Texas, United States +32 more

Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

NCT ID: NCT04930159

The SISTER study is a clinical trial that aims to understand how different types of social support can help Black patients who are undergoing treatment for endometrial cancer. The study is looking ...

Recruiting

Phase: NA Type: interventional Locations: Birmingham, Alabama, United States, Little Rock, Arkansas, United States +10 more

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

NCT ID: NCT06340568

This clinical trial is looking at a new treatment called BNT323/DB-1303 for women with recurring endometrial cancer, which is a type of cancer that starts in the lining of the uterus. The main goal...

Recruiting

Phase: PHASE3 Type: interventional Locations: Taipei City, , Taiwan

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT ID: NCT04585750

The PYNNACLE clinical trial is studying a new treatment called PC14586, aimed at patients with advanced solid tumors that have a specific genetic mutation known as TP53 Y220C. This trial is current...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Charleston, South Carolina, United States +92 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions